Nuveen Asset Management, LLC Cytom X Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.53 - $2.89 $307,442 - $580,725	-200,943 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.67 - $4.68 $3,772 - $6,612	1,413 Added 0.71%	200,943 $621,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $92,632 - $176,887	-23,936 Reduced 10.71%	199,530 $1.23 Million
Q3 2021 Nov 12, 2021	BUY	$4.32 - $6.43 $139,816 - $208,106	32,365 Added 16.94%	223,466 $1.17 Million
Q2 2021 Aug 16, 2021	SELL	$6.33 - $9.91 $2.36 Million - $3.7 Million	-373,466 Reduced 66.15%	191,101 $1.21 Million
Q1 2021 May 17, 2021	SELL	$6.6 - $9.0 $302,471 - $412,461	-45,829 Reduced 7.51%	564,567 $4.37 Million
Q4 2020 Feb 16, 2021	SELL	$6.47 - $7.9 $132,783 - $162,131	-20,523 Reduced 3.25%	610,396 $4 Million
Q3 2020 Nov 16, 2020	SELL	$6.55 - $8.83 $608,377 - $820,148	-92,882 Reduced 12.83%	630,919 $4.2 Million
Q2 2020 Aug 14, 2020	BUY	$7.4 - $14.64 $20,964 - $41,475	2,833 Added 0.39%	723,801 $6.03 Million
Q1 2020 May 14, 2020	BUY	$3.61 - $8.6 $67,362 - $160,476	18,660 Added 2.66%	720,968 $5.53 Million
Q4 2019 Feb 14, 2020	SELL	$5.17 - $8.91 $213,407 - $367,786	-41,278 Reduced 5.55%	702,308 $5.84 Million
Q3 2019 Nov 14, 2019	SELL	$7.38 - $12.25 $6,007 - $9,971	-814 Reduced 0.11%	743,586 $5.49 Million
Q2 2019 Aug 15, 2019	BUY	$9.35 - $11.41 $6.96 Million - $8.49 Million	744,400 New	744,400 $8.35 Million

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $75.8M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.